Pms-duloxetine 30 Mg: Exceeds Acceptable Interim Intake Limit For N-nitroso-duloxetine (ndlx)
PMS-Duloxetine 30 mg capsules are being recalled in Canada because they contain higher-than-acceptable levels of N-nitroso-duloxetine, a chemical impurity. This recall affects all PMS-Duloxetine 30 mg products distributed across Canada. The issue was identified during product quality testing.
- Product
- PMS-Duloxetine 30 mg
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2024-04-17
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/d9efb551-28f8-4870-9d19-9fcb7c6b0e8b